Related Experiment Video
Updated: Apr 18, 2026

07:36
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
Published on: June 12, 2021
7.9K
Methods to study tumor surveillance using tumor cell transplantation into genetically engineered mice
Eva Bauer1, Agnieszka Witalisz, Birgit Strobl
1Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.
Methods in Molecular Biology (Clifton, N.J.)
|February 1, 2015
Summary
This study details protocols for using mouse tumor cell transplantation to investigate how specific genes affect tumor surveillance by the immune system. Researchers can analyze the roles of natural killer cells and T cells in this process.
Area of Science:
- Immunology
- Cancer Research
- Genetics
Background:
- Tumor evolution involves complex interactions between cancer cells and the immune system.
- Studying gene function in tumor surveillance requires models that separate tumor-intrinsic effects from immune responses.
Purpose of the Study:
- To provide standardized protocols for tumor cell transplantation in mice.
- To investigate the role of specific genes in tumor immune surveillance.
- To outline methods for assessing the impact of natural killer (NK) cells and T cells on tumor growth.
Main Methods:
- Utilizing well-characterized, established tumor cell lines for transplantation into mice.
- Employing genetically engineered mouse models to study gene function.
- Implementing techniques such as cell depletion and adoptive cell transfer.
- Analyzing the effects of specific gene products on tumor surveillance.
Main Results:
- Established protocols for reproducible tumor cell transplantation experiments.
- Demonstrated methods to dissect the contribution of specific genes to tumor immune surveillance.
- Provided frameworks for evaluating the roles of NK cells and T cells in controlling tumor progression.
Conclusions:
- Tumor cell transplantation in mice is a robust model for studying tumor-immune system crosstalk.
- Specific gene products significantly influence tumor surveillance mechanisms.
- Further research can leverage these protocols to develop targeted cancer immunotherapies.

